Evidence map›Paper›PMID 37165581›Full record

ArticleTumori2023

Electronic cigarette, or vaping, product use-associated lung injury (EVALI) in a patient with testicular cancer: A case report.

Jacob Stein, Hannah E Kay, Jeremy Sites, Afsaneh Pirzadeh, Benny L Joyner, Toni Darville, Marc A Bjurlin, Tracy L Rose, Ilona Jaspers, Matthew I Milowsky

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Tumori, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Jacob SteinDepartment of Medicine, Division of Hematology/Oncology, UNC Chapel Hill, Chapel Hill, NC, USA.
Hannah E KayDepartment of Urology, UNC Chapel Hill, Chapel Hill, NC, USA.ORCID 0000-0003-2085-9202
Jeremy SitesDepartment of Pediatrics, Division of Pediatric Critical Care Medicine, UNC Chapel Hill, Chapel Hill, NC, USA.
Afsaneh PirzadehDepartment of Pediatrics, Division of Pediatric Critical Care Medicine, UNC Chapel Hill, Chapel Hill, NC, USA.
Benny L JoynerDepartment of Pediatrics, Division of Pediatric Critical Care Medicine, UNC Chapel Hill, Chapel Hill, NC, USA.
Toni DarvilleDepartment of Pediatrics, Division of Pediatric Infectious Disease, UNC Chapel Hill, Chapel Hill, NC, USA.
Marc A BjurlinDepartment of Urology, UNC Chapel Hill, Chapel Hill, NC, USA.
Tracy L RoseDepartment of Medicine, Division of Hematology/Oncology, UNC Chapel Hill, Chapel Hill, NC, USA.
Ilona JaspersDepartment of Pediatrics, Division of Microbiology and Immunology, UNC Chapel Hill, Chapel Hill, NC, USA.
Matthew I MilowskyDepartment of Medicine, Division of Hematology/Oncology, UNC Chapel Hill, Chapel Hill, NC, USA.
University of North Carolina at Chapel Hill · US

Funding

UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Melissa A. Troester · 2001 to 2026
$36.3M
E-cig flavors and their effects on respiratory innate immune responsesR01HL139369 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JASPERS, ILONA · 2017 to 2020
$2.4M
Selective histone deacetylase inhibition with entinostat to enhance the anti-tumor immune response to immune checkpoint inhibition in urothelial cancerK08CA248967 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ROSE, TRACY L · 2020 to 2022
$787k
NCI NIH HHS K08 CA248967NHLBI NIH HHS R01 HL139369NIEHS NIH HHS P30 ES010126
6 · The paper itself

Abstract

Electronic cigarette, or vaping, product use-associated lung injury (EVALI) is an increasingly recognized entity with the potential for severe pulmonary toxicity. We present the case of a young man first evaluated at a tertiary care center in the United States in 2019 with newly diagnosed testicular cancer with acute respiratory failure, which was initially attributed to possible metastatic disease but eventually determined to be related to EVALI. This case highlights the clinical features of EVALI, the potential diagnostic dilemma that can arise with EVALI when occurring in the setting of malignancy and the importance of inquiring about vaping use among patients with malignancy, especially in adolescents and young adults.

Indexed as

Electronic Nicotine Delivery SystemsLung InjuryNeoplasms, Germ Cell and EmbryonalTesticular NeoplasmsVapingAdolescentHumansMaleUnited StatesYoung Adultcase reporte-cigarettelung injurytesticular cancerVaping

Identifiers

PMID37165581
PMCPMC10702303
OpenAlexW4376133190

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.